Atea Pharmaceuticals (AVIR) Other Non-Current Assets (2019 - 2026)

Atea Pharmaceuticals' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $3.0 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 30.63% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $3.0 million (down 30.63% YoY), while the FY2025 annual figure was $3.1 million, up 1491.88% from the prior year.
• Other Non-Current Assets was $3.0 million for Q1 2026 at Atea Pharmaceuticals, down from $3.1 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $5.5 million in Q3 2025 to a low of $197000.0 in Q4 2024.
• Historically, Other Non-Current Assets has averaged $1.7 million across 5 years, with a median of $1.4 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets plunged 85.89% in 2024, then soared 1491.88% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $198000.0 in 2022, then soared by 605.05% to $1.4 million in 2023, then slumped by 85.89% to $197000.0 in 2024, then jumped by 1491.88% to $3.1 million in 2025, then fell by 2.81% to $3.0 million in 2026.
• The last three Other Non-Current Assets figures came in at $3.0 million (Q1 2026), $3.1 million (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.